{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/16/3312427/0/en/Invivyd-Announces-Completion-of-Enrollment-in-Phase-3-LIBERTY-Trial-Evaluating-VYD2311-Antibody-Versus-mRNA-COVID-19-Vaccine.html", "message": "News view counter 801531 successfully enlarged"}